Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Eli Lilly & CO Transaction History
Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P.
- $574 Million
- Q2 2025
A detailed history of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. holds 1,690 shares of LLY stock, worth $1.53 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
1,690
Previous 1,690
-0.0%
Holding current value
$1.53 Million
Previous $1.4 Million
5.59%
% of portfolio
0.23%
Previous 0.22%
Shares
8 transactions
Others Institutions Holding LLY
# of Institutions
4,474Shares Held
779MCall Options Held
16.9MPut Options Held
12.6M-
Lilly Endowment Inc Indianapolis, IN95.5MShares$86.6 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$72.9 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$59.7 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$46.5 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.5MShares$31.3 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $862B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...